Your Chance to Comment: Medicare Data Collection Proposals

You might care about this because the Centers for Medicare & Medicaid Services, or CMS, is asking for your thoughts on two important data collection efforts. These efforts help CMS manage parts of Medicare. The agency must follow rules set by the Paperwork Reduction Act of 1995. This law says that federal agencies must tell the public when they plan to collect information. They also have to let people comment on these plans. This notice gives you 60 days to speak up. You can comment on things like how necessary the information is, if the burden on people is estimated correctly, and how to make the data collection better. Comments are due by September 22, 2026. One collection is about the Medicare Transaction Facilitator, or MTF. This system helps run parts of the Inflation Reduction Act related to drug price negotiation. It handles claims and payment data between drug makers, providers, and pharmacies. Drug manufacturers must participate in the data module of this system. The other collection is about Prescription Drug Event, or PDE, data for Medicare Part D. This data is collected from Part D plan providers. It helps CMS make sure payments for Part D are correct. It also helps with program oversight, checking for accuracy in things like reinsurance and low-income subsidies. Both collections are about gathering necessary information to ensure Medicare programs run smoothly and fairly. What is particularly interesting about this notice is the clear invitation for public involvement in how government agencies collect data. The Paperwork Reduction Act is designed to reduce the amount of paperwork the public has to do for federal agencies. By opening a comment period, CMS is fulfilling its duty to hear from those who will be affected. This means you have a direct way to influence the process. For example, if you are a drug manufacturer, you can comment on the time and effort required to provide data for the Medicare Transaction Facilitator. If you are involved with Medicare Part D plans, you can give feedback on the process for submitting Prescription Drug Event data. This helps ensure the data collection is efficient and does not create unnecessary burdens. It also helps CMS collect the best possible information to administer complex programs like the Inflation Reduction Act's drug negotiation parts and the Medicare Part D prescription drug benefit. Your input helps make these systems better for everyone. This notice would be highly relevant to several groups. Drug manufacturers, especially those with products in Medicare, will find the details about the Medicare Transaction Facilitator very important. They need to understand their mandatory participation in the data module. Healthcare providers, particularly those involved with Medicare Part B, and dispensing entities like pharmacies, will also want to know how the MTF system might impact them. Organizations that offer Medicare Part D plans, such as pharmacy benefit managers, third-party administrators, and other insurers, are directly affected by the Prescription Drug Event data collection. Legal professionals specializing in healthcare law or regulatory compliance would also be interested. Academics or researchers studying health policy, drug pricing, or Medicare program operations could use this information. Finally, any Medicare beneficiary who wants to understand the systems that ensure their drug costs and benefits are managed correctly would find this relevant. It shows how the government works to administer these important programs.